"STABLE CO-FORMULATION OF HYALURONIDASE AND IMMUNOGLOBULIN, AND METHODS OF USE THEREOF"
Provided herein are stable co-formulations of immunoglobulin and hyaluronidase that are stable to storage in liquid form at room temperature for at least 6 months and at standard refrigerator temperatures for 1 -2 years. Such co-formulations can be used in methods of treating IG-treatable diseases o...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
23.10.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Provided herein are stable co-formulations of immunoglobulin and hyaluronidase that are stable to storage in liquid form at room temperature for at least 6 months and at standard refrigerator temperatures for 1 -2 years. Such co-formulations can be used in methods of treating IG-treatable diseases or conditions by subcutaneous administration. |
---|---|
AbstractList | Provided herein are stable co-formulations of immunoglobulin and hyaluronidase that are stable to storage in liquid form at room temperature for at least 6 months and at standard refrigerator temperatures for 1 -2 years. Such co-formulations can be used in methods of treating IG-treatable diseases or conditions by subcutaneous administration. |
Author | SCHWARZ, HANS-PETER TESCHNER, WOLFGANG WEBER, ALFRED BRUCKSCHWAIGER, LEOPOLD LEI, LAURA SVATOS, SONJA |
Author_xml | – fullname: WEBER, ALFRED – fullname: TESCHNER, WOLFGANG – fullname: SVATOS, SONJA – fullname: BRUCKSCHWAIGER, LEOPOLD – fullname: LEI, LAURA – fullname: SCHWARZ, HANS-PETER |
BookMark | eNqNi7sKwjAUQDPo4OsfQsHNgm0nx7S5MYHk3tImiFMpEidpC_X_8YEf4HTgcM6aLYZxiCt2SVovSgu8olRR44IV3hByUlxfhQ0NoZGiBS5QcuNcQDpbKoM1ePg6B16TbD9DeGdeQwOkki1b3vvHHHc_bthega90Gqexi_PU3-IQn53BIs9OEizW-THLRfFv9wJ-5DTf |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | IN3219DELNP2012A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_IN3219DELNP2012A3 |
IEDL.DBID | EVB |
IngestDate | Fri Aug 30 05:42:02 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_IN3219DELNP2012A3 |
Notes | Application Number: IN2012DELNP3219 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151023&DB=EPODOC&CC=IN&NR=3219DEN2012A |
ParticipantIDs | epo_espacenet_IN3219DELNP2012A |
PublicationCentury | 2000 |
PublicationDate | 20151023 |
PublicationDateYYYYMMDD | 2015-10-23 |
PublicationDate_xml | – month: 10 year: 2015 text: 20151023 day: 23 |
PublicationDecade | 2010 |
PublicationYear | 2015 |
RelatedCompanies | BAXTER INTERNATIONAL INC BAXTER HEALTHCARE S.A |
RelatedCompanies_xml | – name: BAXTER INTERNATIONAL INC – name: BAXTER HEALTHCARE S.A |
Score | 3.0042226 |
Snippet | Provided herein are stable co-formulations of immunoglobulin and hyaluronidase that are stable to storage in liquid form at room temperature for at least 6... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | "STABLE CO-FORMULATION OF HYALURONIDASE AND IMMUNOGLOBULIN, AND METHODS OF USE THEREOF" |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151023&DB=EPODOC&locale=&CC=IN&NR=3219DEN2012A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dS8MwED90ivqmU_FzlKF9sri1c3UPRdomtZU2GVur82m0aweCdMNV_Pe9xE190rdwXI7k4HeXu-QuABfdohBtxieabuZTraPnPa1nGqamZ8bULNp5t52KeueIdf2k8zC6Ga3B66oWRvYJ_ZDNERFRE8R7Je31_CeJReTbysV19oKk2Z0XW0RdRsfovtAHqcSxaJ8T7qquawVMZQPLQGQSypBFt9dhAw_SpsADfXREXcr8t1PxdmGzj_LKag_WirIO2-7q77U6bEXLK28cLtG32Ien5jC2nZAqLtcweIuSUCaYFO4p_rMdJgPOAmIPqWIzogRRlDB-H3InCQN2JWkRjX1OhmJCgmyxTweUe80DuPRo7PoarnD8rZBxwL62E7K-3JBxCLVyVhZHoOi32cRsmVMjzY2OODm3WoWeivQOhtBpLz2Gxt-yTv5jOIUdoWhhv3XjDGrV23txjo65yhpSn58HkImO |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT4MwEL_MaZxvOjV-TrIoTxI3mMM9EAO0CArtsoHOpwUGS0wMWxzGf98rbuqTvjWX66W95HfXu_auAOfdLBNtxieKqqdTpaOmPaWna7qiJtpUz9pptx2LeueAdd2ocz-6HlXgdVULU_YJ_SibIyKiJoj3orTX858kFinfVi6ukhckzW6d0CDyMjpG94U-SCaWQfuccFu2bcNjMhsYGiKTUIYsqrkG63jI1gUe6KMl6lLmv52Ksw0bfZSXFztQyfI61OzV32t12AyWV944XKJvsQtPzWFoWj6VbK5g8BZEfplgkrgjuc-mHw0484g5pJLJiOQFQcT4nc-tyPfYZUkLaOhyMhQTImQLXTqg3GnuwYVDQ9tVcIXjb4WMPfa1HZ_1yw1p-1DNZ3l2AJJ6k0z0lj7V4lTriJNzq5WpsUjvYAgd9-JDaPwt6-g_hjOouWHgj3HtD8ewJZQubLmqnUC1eHvPTtFJF0mj1O0nqAiMgQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%22STABLE+CO-FORMULATION+OF+HYALURONIDASE+AND+IMMUNOGLOBULIN%2C+AND+METHODS+OF+USE+THEREOF%22&rft.inventor=WEBER%2C+ALFRED&rft.inventor=TESCHNER%2C+WOLFGANG&rft.inventor=SVATOS%2C+SONJA&rft.inventor=BRUCKSCHWAIGER%2C+LEOPOLD&rft.inventor=LEI%2C+LAURA&rft.inventor=SCHWARZ%2C+HANS-PETER&rft.date=2015-10-23&rft.externalDBID=A&rft.externalDocID=IN3219DELNP2012A |